Jazz Pharmaceuticals plc (JAZZ)
USD 110.51
(-8.54%)
USD 110.51
(-8.54%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7.65 Billion USD | -1.2% |
| 2022 | 7.74 Billion USD | -7.01% |
| 2021 | 8.33 Billion USD | 189.74% |
| 2020 | 2.87 Billion USD | 18.46% |
| 2019 | 2.42 Billion USD | -0.74% |
| 2018 | 2.44 Billion USD | 1.47% |
| 2017 | 2.41 Billion USD | -17.53% |
| 2016 | 2.92 Billion USD | 65.98% |
| 2015 | 1.76 Billion USD | -10.51% |
| 2014 | 1.96 Billion USD | 108.74% |
| 2013 | 942.68 Million USD | 11.53% |
| 2012 | 845.2 Million USD | 1290.48% |
| 2011 | 60.78 Million USD | -42.21% |
| 2010 | 105.17 Million USD | -41.64% |
| 2009 | 180.22 Million USD | -14.33% |
| 2008 | 210.37 Million USD | 37.9% |
| 2007 | 152.56 Million USD | -60.97% |
| 2006 | 390.86 Million USD | 38.1% |
| 2005 | 283.02 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 7.59 Billion USD | -0.41% |
| 2024 Q1 | 7.63 Billion USD | -0.34% |
| 2023 Q4 | 7.65 Billion USD | -0.76% |
| 2023 Q2 | 7.73 Billion USD | 0.3% |
| 2023 Q1 | 7.71 Billion USD | -0.48% |
| 2023 Q3 | 7.71 Billion USD | -0.26% |
| 2023 FY | 7.65 Billion USD | -1.2% |
| 2022 Q4 | 7.74 Billion USD | 1.44% |
| 2022 Q2 | 7.99 Billion USD | -1.97% |
| 2022 FY | 7.74 Billion USD | -7.01% |
| 2022 Q1 | 8.16 Billion USD | -2.08% |
| 2022 Q3 | 7.63 Billion USD | -4.5% |
| 2021 Q3 | 8.53 Billion USD | -5.97% |
| 2021 Q2 | 9.08 Billion USD | 206.93% |
| 2021 FY | 8.33 Billion USD | 189.74% |
| 2021 Q1 | 2.95 Billion USD | 2.87% |
| 2021 Q4 | 8.33 Billion USD | -2.41% |
| 2020 Q2 | 2.92 Billion USD | 21.52% |
| 2020 Q1 | 2.4 Billion USD | -0.87% |
| 2020 Q4 | 2.87 Billion USD | -1.32% |
| 2020 Q3 | 2.91 Billion USD | -0.34% |
| 2020 FY | 2.87 Billion USD | 18.46% |
| 2019 Q3 | 2.47 Billion USD | -1.27% |
| 2019 Q4 | 2.42 Billion USD | -1.84% |
| 2019 FY | 2.42 Billion USD | -0.74% |
| 2019 Q1 | 2.54 Billion USD | 4.24% |
| 2019 Q2 | 2.5 Billion USD | -1.75% |
| 2018 Q4 | 2.44 Billion USD | -0.5% |
| 2018 Q2 | 2.47 Billion USD | -0.85% |
| 2018 Q1 | 2.5 Billion USD | 3.73% |
| 2018 FY | 2.44 Billion USD | 1.47% |
| 2018 Q3 | 2.45 Billion USD | -0.84% |
| 2017 Q3 | 2.52 Billion USD | -2.81% |
| 2017 Q2 | 2.6 Billion USD | -8.08% |
| 2017 FY | 2.41 Billion USD | -17.53% |
| 2017 Q1 | 2.83 Billion USD | -3.12% |
| 2017 Q4 | 2.41 Billion USD | -4.71% |
| 2016 Q1 | 1.92 Billion USD | 9.46% |
| 2016 FY | 2.92 Billion USD | 65.98% |
| 2016 Q4 | 2.92 Billion USD | -9.07% |
| 2016 Q3 | 3.21 Billion USD | 83.1% |
| 2016 Q2 | 1.75 Billion USD | -8.92% |
| 2015 Q1 | 1.93 Billion USD | -1.8% |
| 2015 FY | 1.76 Billion USD | -10.51% |
| 2015 Q2 | 1.94 Billion USD | 0.73% |
| 2015 Q3 | 1.9 Billion USD | -2.34% |
| 2015 Q4 | 1.76 Billion USD | -7.36% |
| 2014 FY | 1.96 Billion USD | 108.74% |
| 2014 Q4 | 1.96 Billion USD | -1.95% |
| 2014 Q3 | 2 Billion USD | 7.0% |
| 2014 Q2 | 1.87 Billion USD | -2.81% |
| 2014 Q1 | 1.92 Billion USD | 104.73% |
| 2013 Q3 | 941.79 Million USD | 2.54% |
| 2013 FY | 942.68 Million USD | 11.53% |
| 2013 Q4 | 942.68 Million USD | 0.09% |
| 2013 Q2 | 918.42 Million USD | 8.33% |
| 2013 Q1 | 847.79 Million USD | 0.31% |
| 2012 FY | 845.2 Million USD | 1290.48% |
| 2012 Q4 | 845.2 Million USD | 0.55% |
| 2012 Q1 | 113.52 Million USD | 86.77% |
| 2012 Q2 | 866.48 Million USD | 663.23% |
| 2012 Q3 | 840.61 Million USD | -2.99% |
| 2011 Q3 | 66.48 Million USD | -27.59% |
| 2011 FY | 60.78 Million USD | -42.21% |
| 2011 Q1 | 94.1 Million USD | -10.53% |
| 2011 Q2 | 91.81 Million USD | -2.44% |
| 2011 Q4 | 60.78 Million USD | -8.57% |
| 2010 Q3 | 108.8 Million USD | -4.2% |
| 2010 FY | 105.17 Million USD | -41.64% |
| 2010 Q2 | 113.56 Million USD | -35.37% |
| 2010 Q1 | 175.7 Million USD | -2.51% |
| 2010 Q4 | 105.17 Million USD | -3.33% |
| 2009 FY | 180.22 Million USD | -14.33% |
| 2009 Q4 | 180.22 Million USD | -2.38% |
| 2009 Q3 | 184.61 Million USD | -6.51% |
| 2009 Q2 | 197.47 Million USD | -2.35% |
| 2009 Q1 | 202.23 Million USD | -3.87% |
| 2008 Q3 | 217.97 Million USD | -1.91% |
| 2008 Q4 | 210.37 Million USD | -3.48% |
| 2008 Q2 | 222.21 Million USD | -1.93% |
| 2008 FY | 210.37 Million USD | 37.9% |
| 2008 Q1 | 226.57 Million USD | 48.51% |
| 2007 Q4 | 152.56 Million USD | 3.73% |
| 2007 Q1 | 122.09 Million USD | -68.76% |
| 2007 Q2 | 147.79 Million USD | 21.05% |
| 2007 Q3 | 147.07 Million USD | -0.48% |
| 2007 FY | 152.56 Million USD | -60.97% |
| 2006 FY | 390.86 Million USD | 38.1% |
| 2006 Q4 | 390.86 Million USD | 0.0% |
| 2005 Q4 | 283.02 Million USD | 0.0% |
| 2005 FY | 283.02 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -2180.199% |
| Alkermes plc | 933.53 Million USD | -720.146% |
| Agenus Inc. | 462.29 Million USD | -1556.164% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | -89.022% |
| Aptorum Group Limited | 5.25 Million USD | -145548.537% |
| Ardelyx, Inc. | 130.76 Million USD | -5755.144% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -1500.444% |
| Bicycle Therapeutics plc | 224.41 Million USD | -3311.744% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -5780.011% |
| ChromaDex Corporation | 26.5 Million USD | -28783.213% |
| Chimerix, Inc. | 19.74 Million USD | -38676.207% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -21665.179% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -10450.749% |
| CRISPR Therapeutics AG | 346.76 Million USD | -2107.921% |
| Precision BioSciences, Inc. | 140.92 Million USD | -5333.127% |
| Dyadic International, Inc. | 2.34 Million USD | -327003.955% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -46978.411% |
| Fortress Biotech, Inc. | 165.93 Million USD | -4513.962% |
| Lantern Pharma Inc. | 2.73 Million USD | -279361.704% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -10611.195% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -216872.476% |
| Incyte Corporation | 1.59 Billion USD | -380.846% |
| IO Biotech, Inc. | 17.55 Million USD | -43511.085% |
| Jaguar Health, Inc. | 45.86 Million USD | -16592.892% |
| Novavax, Inc. | 2.57 Billion USD | -197.65% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -21133.463% |
| Opthea Limited | 264.6 Million USD | -2793.547% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -5757.653% |
| ContextLogic Inc. | 206 Million USD | -3616.681% |
| MiMedx Group, Inc. | 96.33 Million USD | -7848.056% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -15843.447% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -216862.515% |
| NextCure, Inc. | 14.99 Million USD | -50952.624% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -189320.139% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -114567.695% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -16281.099% |
| Vaxcyte, Inc. | 167.44 Million USD | -4472.355% |
| PDS Biotechnology Corporation | 33.25 Million USD | -22920.329% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -3155.062% |
| Pharming Group N.V. | 244.07 Million USD | -3036.915% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -64120.45% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -5891.316% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -115777.686% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -115777.686% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -9187.982% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -115154.584% |
| Acelyrin, Inc. | 86.35 Million USD | -8766.353% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -589194.981% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -53146.832% |
| Summit Therapeutics Inc. | 125.25 Million USD | -6012.522% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -80671.832% |
| Senti Biosciences, Inc. | 52.57 Million USD | -14463.851% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -11032.155% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -4953.304% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -391329.55% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -573168.073% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -3275.345% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -81637.611% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -3266.248% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -1448.276% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -70051.75% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -27730.184% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -63151.156% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -1473.437% |
| Immix Biopharma, Inc. | 3.72 Million USD | -205617.582% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -20148.498% |
| MEI Pharma, Inc. | 8.35 Million USD | -91538.085% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -26287.6% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -2102.763% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -5148.793% |
| Fortress Biotech, Inc. | 165.93 Million USD | -4513.962% |
| Precigen, Inc. | 41.64 Million USD | -18285.27% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -15234.192% |
| AlloVir, Inc. | 45.01 Million USD | -16908.468% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -5774.281% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -5456.141% |
| ImmuCell Corporation | 18.81 Million USD | -40592.808% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -27025.211% |
| Onconetix, Inc. | 23.18 Million USD | -32928.769% |
| PureTech Health plc | 125.58 Million USD | -5996.655% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -85445.944% |
| Elevation Oncology, Inc. | 34.28 Million USD | -22233.475% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -313043.64% |
| Seer, Inc. | 39.36 Million USD | -19349.668% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -12282.123% |
| Innoviva, Inc. | 568.55 Million USD | -1246.642% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -28019.443% |
| ESSA Pharma Inc. | 3.49 Million USD | -218961.701% |
| GlycoMimetics, Inc. | 6.9 Million USD | -110828.425% |
| GT Biopharma, Inc. | 6.63 Million USD | -115328.343% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -2795.859% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -2711.872% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -9011.896% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -78233.968% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -28080.507% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -237249.683% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -10279.115% |
| Aptose Biosciences Inc. | 15.8 Million USD | -48331.316% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -69253.078% |
| Soligenix, Inc. | 7.27 Million USD | -105143.478% |
| Century Therapeutics, Inc. | 175.94 Million USD | -4251.664% |
| Kura Oncology, Inc. | 51.66 Million USD | -14720.104% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -6212.859% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -185149.504% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -115662.471% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -2931.046% |
| Autolus Therapeutics plc | 263.9 Million USD | -2801.159% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -72942.95% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -8516.111% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -16225.214% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -2069.826% |
| GRI Bio, Inc. | 2.69 Million USD | -283784.39% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -945614.409% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -24525.654% |
| IGM Biosciences, Inc. | 220.17 Million USD | -3377.367% |
| INmune Bio, Inc. | 18.86 Million USD | -40491.464% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -2885.181% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -28638.143% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -281548.952% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -233306.742% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -12997.874% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -7862.19% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -2792.085% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -830.266% |
| Verastem, Inc. | 71.18 Million USD | -10655.583% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -15469.306% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -19746.446% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -15546.943% |
| Histogen Inc. | 5.69 Million USD | -134292.873% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -174479.38% |
| Surrozen, Inc. | 8.14 Million USD | -93900.761% |
| Organovo Holdings, Inc. | 2.74 Million USD | -278515.793% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -2439335.031% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -13516.177% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -46268.471% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -14882.216% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -925839.471% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -5941.714% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -70703.147% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -4974.168% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -293545.912% |
| Apollomics, Inc. | 14.15 Million USD | -53997.096% |
| Amarin Corporation plc | 279.58 Million USD | -2638.454% |
| Mesoblast Limited | 188.79 Million USD | -3955.319% |
| Turnstone Biologics Corp. | 14.14 Million USD | -54016.214% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -4134.995% |
| Synaptogenix, Inc. | 5.52 Million USD | -138364.688% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -115067.9% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -4400.883% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -89372.821% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -435565.898% |
| Exelixis, Inc. | 678.44 Million USD | -1028.516% |
| Better Therapeutics, Inc. | 23.84 Million USD | -32012.918% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -4567.204% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -1188.496% |
| NLS Pharmaceutics AG | 10.68 Million USD | -71587.413% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -471462.364% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -19568.513% |
| Gritstone bio, Inc. | 125.91 Million USD | -5980.387% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -52069.27% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -150360.272% |
| Avid Bioservices, Inc. | 275.66 Million USD | -2677.385% |
| Insmed Incorporated | 1.66 Billion USD | -360.738% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -99410.503% |
| MediWound Ltd. | 27.18 Million USD | -28061.849% |
| OmniAb, Inc. | 87.4 Million USD | -8660.14% |
| Alector, Inc. | 487.66 Million USD | -1469.992% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -1797.694% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -41454.204% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -19852.472% |
| Zai Lab Limited | 240.17 Million USD | -3087.8% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -1115.184% |
| Aura Biosciences, Inc. | 29.22 Million USD | -26096.195% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -7952.801% |
| Immunic, Inc. | 25.36 Million USD | -30081.181% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -10958.354% |
| Veracyte, Inc. | 93.71 Million USD | -8069.488% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -292499.113% |
| FibroGen, Inc. | 585.72 Million USD | -1207.153% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -43945.113% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -1172253.907% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -135280.052% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -93293.047% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -9012.33% |
| TG Therapeutics, Inc. | 169.08 Million USD | -4428.114% |
| Galecto, Inc. | 5.89 Million USD | -129756.886% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -92323.491% |
| Fortrea Holdings Inc. | 2.61 Billion USD | -192.406% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -26464.298% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -60563.672% |
| XBiotech Inc. | 8.39 Million USD | -91079.731% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -52069.27% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -14297.07% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -2008.575% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -28379.252% |
| Theravance Biopharma, Inc. | 169 Million USD | -4430.284% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -529.843% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -1429.969% |
| Vaxxinity, Inc. | 30.94 Million USD | -24642.638% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -687.296% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -126847.872% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -927.377% |
| NexImmune, Inc. | 5.08 Million USD | -150490.335% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -2061420.111% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -248899.69% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | -7.728% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -148450.979% |
| Scopus BioPharma Inc. | 7.45 Million USD | -102608.831% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -29018.286% |
| Ainos, Inc. | 7.39 Million USD | -103445.187% |
| Pluri Inc. | 34.11 Million USD | -22344.776% |
| Prothena Corporation plc | 135.01 Million USD | -5570.665% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -3049.431% |
| Celularity Inc. | 102.92 Million USD | -7338.489% |
| Rallybio Corporation | 9.43 Million USD | -81039.911% |
| Cue Biopharma, Inc. | 24.44 Million USD | -31220.769% |
| MeiraGTx Holdings plc | 319.99 Million USD | -2292.68% |
| Omeros Corporation | 403.25 Million USD | -1798.654% |
| Humacyte, Inc. | 114.67 Million USD | -6576.458% |
| Immunocore Holdings plc | 228.15 Million USD | -3255.728% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -156953.579% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -9877.016% |
| Blueprint Medicines Corporation | 918.64 Million USD | -733.444% |
| CalciMedica, Inc. | 4.02 Million USD | -189978.5% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -43770.972% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -4867.051% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -8821.731% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -2656.139% |
| Pulmatrix, Inc. | 15.96 Million USD | -47863.177% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -48440.937% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -31015.834% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -2952.679% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -14975.731% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -532.423% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -23989.488% |
| Nutriband Inc. | 1.07 Million USD | -709532.697% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -71905.662% |
| Vor Biopharma Inc. | 59.1 Million USD | -12854.05% |
| Roivant Sciences Ltd. | 773.95 Million USD | -889.254% |
| Evogene Ltd. | 17.99 Million USD | -42458.988% |
| ProKidney Corp. | 29.21 Million USD | -26106.058% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -10536.939% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -1085934.982% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -305.331% |
| CorMedix Inc. | 11.91 Million USD | -64144.548% |
| BioLineRx Ltd. | 50.7 Million USD | -15000.71% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -5022.717% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -8557.028% |
| Atai Life Sciences N.V. | 49.16 Million USD | -15473.74% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -24477.192% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -42525.331% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -6042.978% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -135314.963% |
| MediciNova, Inc. | 3.89 Million USD | -196643.1% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -41786.11% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -508885.063% |
| GeoVax Labs, Inc. | 3.51 Million USD | -217417.638% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -1827.297% |
| Biomea Fusion, Inc. | 30.69 Million USD | -24847.416% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | -181.304% |
| Mereo BioPharma Group plc | 15.96 Million USD | -47866.182% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -24438.835% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -12946.762% |
| Absci Corporation | 58.3 Million USD | -13031.795% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -40095.097% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -23779.865% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -10275.88% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -8651.828% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -22572.082% |
| Allakos Inc. | 74.79 Million USD | -10136.736% |
| Imunon, Inc. | 8.53 Million USD | -89653.561% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -33926.763% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -6568.608% |
| BioAtla, Inc. | 48.98 Million USD | -15529.694% |
| NLS Pharmaceutics AG | 10.68 Million USD | -71587.413% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -275407.809% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -5762.272% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -53761.147% |
| XOMA Corporation | 145.58 Million USD | -5159.213% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -22642.795% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -11035.069% |
| aTyr Pharma, Inc. | 31.59 Million USD | -24131.294% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -12284.326% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -16927.381% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -15718.276% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -266672.195% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -93750.761% |
| Akari Therapeutics, Plc | 4.58 Million USD | -166923.604% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -43075.469% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -364.173% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1895470.774% |
| UroGen Pharma Ltd. | 243.52 Million USD | -3044.0% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -2284.513% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -277147.916% |
| Orgenesis Inc. | 35.53 Million USD | -21445.974% |
| Entera Bio Ltd. | 1.37 Million USD | -555111.168% |
| GH Research PLC | 6.7 Million USD | -114157.006% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -112493.559% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -40569.085% |
| Xencor, Inc. | 283.55 Million USD | -2600.095% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -256336.551% |
| Replimune Group, Inc. | 113.21 Million USD | -6662.734% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -203682.467% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -7295.308% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1895470.774% |
| Portage Biotech Inc. | 4.45 Million USD | -171953.079% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -508885.063% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -33116.321% |
| OncoCyte Corporation | 49.29 Million USD | -15430.776% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -184979.113% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -959964.653% |
| Purple Biotech Ltd. | 10 Million USD | -76425.357% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -132225.648% |
| scPharmaceuticals Inc. | 57.26 Million USD | -13270.989% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -61704.561% |
| HilleVax, Inc. | 78.9 Million USD | -9602.774% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -151511.129% |
| Tharimmune, Inc. | 1.81 Million USD | -421727.436% |
| Genprex, Inc. | 3.25 Million USD | -235175.741% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -28132.464% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -146125.401% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -3716580.583% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -2135279.921% |
| OKYO Pharma Limited | 7.42 Million USD | -103073.708% |
| Savara Inc. | 37.19 Million USD | -20486.045% |
| Curis, Inc. | 57.61 Million USD | -13189.526% |
| Daré Bioscience, Inc. | 26.32 Million USD | -28978.633% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -19431.639% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -530118.975% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -36675.839% |
| BeiGene, Ltd. | 2.23 Billion USD | -242.759% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -35862.583% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -2817.854% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -35889.292% |
| Erasca, Inc. | 78.61 Million USD | -9639.556% |
| bluebird bio, Inc. | 424.62 Million USD | -1703.092% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -1168360.684% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -305.087% |
| DBV Technologies S.A. | 42.8 Million USD | -17788.696% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -1168360.684% |
| Moderna, Inc. | 4.57 Billion USD | -67.462% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -109354.782% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -462240.7% |
| Molecular Templates, Inc. | 31.17 Million USD | -24462.452% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -44752.736% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -1201.874% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -6049.441% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -27805.245% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -20901.651% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -13661.772% |
| MacroGenics, Inc. | 154.2 Million USD | -4864.99% |
| RenovoRx, Inc. | 4.46 Million USD | -171336.677% |
| Adicet Bio, Inc. | 37.12 Million USD | -20525.975% |
| Prime Medicine, Inc. | 60.78 Million USD | -12496.844% |
| Aditxt, Inc. | 28.53 Million USD | -26734.714% |
| Adagene Inc. | 45.16 Million USD | -16850.351% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -4236933.553% |
| Quantum-Si incorporated | 26.63 Million USD | -28649.81% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -997.582% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -251552.195% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -6559.965% |
| SciSparc Ltd. | 1.59 Million USD | -479922.696% |
| Vericel Corporation | 127.7 Million USD | -5895.35% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -137483.25% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -8869.696% |
| Generation Bio Co. | 171.63 Million USD | -4360.97% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -66188.848% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -18203.081% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -2929.847% |
| Invivyd, Inc. | 51.71 Million USD | -14705.488% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -8224.214% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -117595.105% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -10041.414% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -749788.541% |
| 2seventy bio, Inc. | 310.12 Million USD | -2368.791% |
| ADMA Biologics, Inc. | 193.97 Million USD | -3847.067% |
| Clene Inc. | 38.95 Million USD | -19556.394% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -21089.471% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -2879.407% |
| GeoVax Labs, Inc. | 3.51 Million USD | -217417.638% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -3924.094% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -62761.859% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -3760.571% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -62683.826% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -15813.953% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -14389.434% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -1970.104% |
| Evaxion Biotech A/S | 17.61 Million USD | -43358.894% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -4657.602% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -4898.082% |
| Trevena, Inc. | 48.26 Million USD | -15764.162% |
| Surrozen, Inc. | 8.14 Million USD | -93900.761% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -35354.327% |
| Cingulate Inc. | 10.36 Million USD | -73796.938% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -278313.164% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -20430.843% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -213376.072% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -58123.285% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -2313.726% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -30711.55% |
| Clearmind Medicine Inc. | 3.61 Million USD | -211987.12% |
| Kronos Bio, Inc. | 54.2 Million USD | -14025.869% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -16175.242% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -33539.948% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -38046.39% |
| Statera Biopharma, Inc. | 22.67 Million USD | -33663.49% |
| ImmunityBio, Inc. | 1.09 Billion USD | -602.168% |
| Korro Bio, Inc. | 51.75 Million USD | -14694.331% |
| Kineta, Inc. | 7.22 Million USD | -105914.428% |
| BioVie Inc. | 9.7 Million USD | -78814.238% |
| Codexis, Inc. | 49.94 Million USD | -15229.28% |
| Celularity Inc. | 102.92 Million USD | -7338.489% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -7854.91% |
| Celcuity Inc. | 51.45 Million USD | -14781.148% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -2217888.146% |
| Cibus, Inc. | 206.11 Million USD | -3614.571% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -17925.573% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -28968.537% |
| IN8bio, Inc. | 8.77 Million USD | -87181.829% |
| Kodiak Sciences Inc. | 213.59 Million USD | -3484.59% |
| Annexon, Inc. | 47.11 Million USD | -16149.336% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -8450.677% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -7844.592% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -55830.762% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | -194.092% |
| Eyenovia, Inc. | 19.78 Million USD | -38607.046% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -4223.528% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -99579.234% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -31670.455% |
| Arcellx, Inc. | 339.75 Million USD | -2153.515% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -64249.992% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -3018.173% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -79962.344% |
| Moolec Science SA | 13.94 Million USD | -54802.593% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -17642.774% |
| Geron Corporation | 146.12 Million USD | -5139.526% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -15051.512% |
| Royalty Pharma plc | 6.29 Billion USD | -21.577% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -19148.698% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -2600513.439% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -311098.554% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -3947.644% |
| Humacyte, Inc. | 114.67 Million USD | -6576.458% |
| Structure Therapeutics Inc. | 29.05 Million USD | -26254.895% |
| 89bio, Inc. | 59.96 Million USD | -12668.477% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -28832.328% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -640064.047% |
| Genelux Corporation | 8.42 Million USD | -90830.665% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -111573.891% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -5516.504% |
| Notable Labs, Ltd. | 4.42 Million USD | -172846.962% |
| Liquidia Corporation | 73.13 Million USD | -10368.378% |
| Mustang Bio, Inc. | 17.61 Million USD | -43355.145% |
| Immunovant, Inc. | 48.95 Million USD | -15539.591% |
| Quantum-Si incorporated | 26.63 Million USD | -28649.81% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -19847.274% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -246640.638% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -10265.906% |
| Acasti Pharma Inc. | 11.55 Million USD | -66148.698% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -33766.125% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -281548.952% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -20661.89% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -561693.81% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -125496.49% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -30728.919% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -32924.336% |
| PepGen Inc. | 34.63 Million USD | -22008.406% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -62946.459% |
| United Therapeutics Corporation | 1.18 Billion USD | -547.637% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -109527.176% |
| Solid Biosciences Inc. | 38.45 Million USD | -19808.373% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -89372.821% |
| Immuneering Corporation | 12 Million USD | -63658.625% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -2439335.031% |
| Silo Pharma, Inc. | 1.56 Million USD | -487793.224% |
| Belite Bio, Inc | 4.21 Million USD | -181718.143% |
| XOMA Corporation | 145.58 Million USD | -5159.213% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -315236.161% |
| Bionomics Limited | 10.15 Million USD | -75267.381% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -35525.899% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -33314.926% |
| uniQure N.V. | 624.01 Million USD | -1126.944% |
| Cassava Sciences, Inc. | 14.19 Million USD | -53837.034% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -4236933.553% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -4398.873% |
| Forte Biosciences, Inc. | 3.66 Million USD | -208747.845% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -2938066.342% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -113378.02% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -99579.234% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -43945.113% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -72348.543% |
| Altimmune, Inc. | 16.54 Million USD | -46187.177% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -1139.483% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -33314.926% |
| Compugen Ltd. | 55.77 Million USD | -13627.229% |
| Peak Bio, Inc. | 20.75 Million USD | -36792.149% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -6831.155% |
| Benitec Biopharma Inc. | 4.96 Million USD | -154199.919% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -4750.619% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -10084.854% |
| Zura Bio Limited | 21.29 Million USD | -35858.867% |
| PolyPid Ltd. | 17.46 Million USD | -43730.788% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -6711.771% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -10084.854% |
| Instil Bio, Inc. | 99.8 Million USD | -7571.629% |
| argenx SE | 444.95 Million USD | -1620.72% |
| Immunome, Inc. | 28.65 Million USD | -26616.317% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -91735.936% |
| Verona Pharma plc | 58.84 Million USD | -12911.951% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -52801.002% |
| Shattuck Labs, Inc. | 14.85 Million USD | -51426.765% |
| CervoMed Inc. | 2.59 Million USD | -294857.945% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -156985.802% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -60015.908% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -72575.482% |
| Moolec Science SA | 13.94 Million USD | -54802.593% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -326605.736% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -13671.601% |
| AnaptysBio, Inc. | 364.28 Million USD | -2001.745% |
| Design Therapeutics, Inc. | 11.95 Million USD | -63937.822% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -60262.362% |
| NeurAxis, Inc. | 1.91 Million USD | -400182.631% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -19568.008% |
| Lumos Pharma, Inc. | 13.33 Million USD | -57324.151% |
| Achilles Therapeutics plc | 19.08 Million USD | -40012.967% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -52801.002% |
| 180 Life Sciences Corp. | 5.38 Million USD | -142021.124% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -32358.73% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -33539.948% |
| Nutriband Inc. | 1.07 Million USD | -709532.697% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -24922.426% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -52662.47% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -1808.013% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -23477.624% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -58573.505% |
| Palisade Bio, Inc. | 2.73 Million USD | -279431.289% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -145652.18% |
| Beam Therapeutics Inc. | 478.38 Million USD | -1500.46% |
| Neurogene Inc. | 36.54 Million USD | -20848.212% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -1823.946% |
| AEON Biopharma, Inc. | 159.88 Million USD | -4688.548% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -15967.916% |
| Sesen Bio, Inc. | 30.98 Million USD | -24610.696% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -29391.784% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -100612.24% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -3811.536% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -3886.505% |
| Athira Pharma, Inc. | 30.05 Million USD | -25372.808% |
| Vaccinex, Inc. | 5.94 Million USD | -128751.599% |
| HCW Biologics Inc. | 15.05 Million USD | -50766.27% |
| XOMA Corporation | 145.58 Million USD | -5159.213% |
| Nektar Therapeutics | 267.04 Million USD | -2767.057% |
| Arvinas, Inc. | 644.6 Million USD | -1087.769% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -43075.469% |
| Merus N.V. | 102.15 Million USD | -7395.142% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -5131.542% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -7949.161% |
| Rezolute, Inc. | 11.73 Million USD | -65149.378% |
| Clene Inc. | 38.95 Million USD | -19556.394% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -268791.472% |
| BeyondSpring Inc. | 48.26 Million USD | -15761.862% |
| Synlogic, Inc. | 32.89 Million USD | -23175.154% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -52294.183% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -468465.606% |
| Peak Bio, Inc. | 20.75 Million USD | -36792.149% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -11965.053% |
| Krystal Biotech, Inc. | 39.71 Million USD | -19178.748% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -1932.785% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -7589.504% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -1769232.557% |
| MannKind Corporation | 721.36 Million USD | -961.37% |
| Ikena Oncology, Inc. | 22.33 Million USD | -34179.66% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -366935.57% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -7363.069% |
| Gossamer Bio, Inc. | 249.14 Million USD | -2973.03% |
| CohBar, Inc. | 1.03 Million USD | -740619.865% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -71528.422% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -40095.097% |
| Legend Biotech Corporation | 589.93 Million USD | -1197.836% |
| Mural Oncology plc | 37.92 Million USD | -20086.569% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -5672.461% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -333462.291% |
| Disc Medicine, Inc. | 22.87 Million USD | -33370.435% |
| Champions Oncology, Inc. | 28.03 Million USD | -27210.012% |
| REGENXBIO Inc. | 262.22 Million USD | -2819.735% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -227811.871% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -60984.745% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -56902.491% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -36006.399% |
| Vaxart, Inc. | 34.02 Million USD | -22402.166% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -37450.948% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -26734.41% |
| Cellectis S.A. | 249.57 Million USD | -2967.76% |
| Longeveron Inc. | 5.33 Million USD | -143358.16% |
| Repare Therapeutics Inc. | 41.81 Million USD | -18208.334% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | -218.32% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -12582.815% |
| Revolution Medicines, Inc. | 262.39 Million USD | -2817.854% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -363277.409% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -88659.124% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -64778.926% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -54420.843% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -355844.305% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | -48.673% |
| Denali Therapeutics Inc. | 122.96 Million USD | -6126.558% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -137483.25% |
| Veru Inc. | 32.81 Million USD | -23233.528% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -111362.542% |
| Cingulate Inc. | 10.36 Million USD | -73796.938% |
| Passage Bio, Inc. | 39.26 Million USD | -19400.693% |
| Context Therapeutics Inc. | 4.19 Million USD | -182554.641% |
| Exicure, Inc. | 8.54 Million USD | -89458.568% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -25846.733% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -72915.087% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -34636.908% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -4597.558% |
| Nuvalent, Inc. | 31.82 Million USD | -23959.209% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -120252.262% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -12048.713% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -42435.344% |
| OmniAb, Inc. | 87.4 Million USD | -8660.14% |
| Anew Medical, Inc. | 8.24 Million USD | -92796.733% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -19896.195% |
| Lipocine Inc. | 2.63 Million USD | -290836.222% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -29042.669% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -18939.993% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -28638.143% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -8786.833% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -141658.23% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -9152.737% |
| Ocugen, Inc. | 23.98 Million USD | -31824.121% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -16398.291% |
| Q32 Bio Inc. | 233.12 Million USD | -3184.188% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -84351.379% |
| Alumis Inc. Common Stock | 53.5 Million USD | -14210.422% |
| Equillium, Inc. | 27.95 Million USD | -27286.207% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -3606.03% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -135972.825% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -124739.425% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -4766.559% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -10926.979% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -76661.657% |
| Dominari Holdings Inc. | 4.63 Million USD | -165085.804% |
| Edesa Biotech, Inc. | 1.84 Million USD | -415636.76% |
| vTv Therapeutics Inc. | 29.56 Million USD | -25794.957% |
| Bio-Techne Corporation | 744.34 Million USD | -928.611% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -5971.707% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -2122.74% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -18769.654% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -26340.453% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -8189.695% |
| Nkarta, Inc. | 105.6 Million USD | -7150.343% |
| BioCardia, Inc. | 4.59 Million USD | -166705.272% |
| Iterum Therapeutics plc | 32.66 Million USD | -23341.192% |